A single-center randomized double-blind placebo-controlled trial "Treatment of Systemic Sclerosis with Rituximab: evaluation of the effectiveness of B-cell depletion therapy"

Trial Profile

A single-center randomized double-blind placebo-controlled trial "Treatment of Systemic Sclerosis with Rituximab: evaluation of the effectiveness of B-cell depletion therapy"

Recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Sep 2015

At a glance

  • Drugs Rituximab (Primary)
  • Indications Systemic scleroderma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 01 Sep 2015 Interim results (n=6, after one treatment course) published in the Clinical and Experimental Rheumatology.
    • 24 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top